BIA 28-6156 clinical trials

Compassionate Use for BIA 28-6156 in Patients With Parkinson's Disease (PD) Who Have a Pathogenic Variant in the GBA1 Gene (GBA-PD) and Completed the ACTIVATE Study

This programme offers continued access to an investigational drug, BIA 28-6156, for people with a specific type of Parkinson's disease (related to the GBA1 gene) who have already completed a previous study. It provides the medicine free of charge on compassionate grounds.